Genome-wide association studies (GWAS) are powerful tools for discovering the genetic contributions to common diseases. Early findings from such studies have identified new genetic variants associated with a higher risk of common diseases including diabetes and heart disease. Genetic studies funded today will identify many novel genetic variants associated with an increased risk for these health conditions.
These new educational Webinars provide critical insight into why genetics, genomics and translational biology are important in both clinical and basic science. Whole genome information, when combined with clinical and other phenotype data, offers the potential for increased understanding of basic biological processes affecting human health, improvement in the prediction of disease and patient care, and ultimately the realization of the promise of personalized medicine.
Presented Thursday, Jan. 14, 2010
|View the archived Webcast|
|Jennifer E. Van Eyk, Ph.D.|
Johns Hopkins University
|Rob E. Gerszten, M.D.|
Massachusetts General Hospital
Presented Monday, April 5, 2010
Joseph Loscalzo, M.D., Ph.D.
Chairman, Department of Medicine
Brigham and Women's Hospital
Presented Thursday, July 8, 2010
Are Genome-wide Association Studies Useful?
|Monday, Oct. 4, 2010, 11 a.m. Eastern Time|
View the archived webcast!
Frontiers of the Proteome: Application to Biology
The American Heart Association gratefully acknowledges the educational grants from the following:
All Webinars in this series are free of charge.